Header Logo

Connection

Matthew Daley to United States

Back to Details
This is a "connection" page, showing publications Matthew Daley has written about United States.
Matthew Daley
Connection Strength
2.222
United States
  1. Beyond Vaccination Coverage: Population-Based Measurement of Early Childhood Immunization Schedule Adherence. Acad Pediatr. 2023 Jan-Feb; 23(1):24-34.
    View in: PubMed
    Score: 0.112
  2. Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine: Updated Interim Recommendations from the Advisory Committee on Immunization Practices - United States, December 2021. MMWR Morb Mortal Wkly Rep. 2022 Jan 21; 71(3):90-95.
    View in: PubMed
    Score: 0.107
  3. A Mixed-Methods Analysis of Barriers to and Facilitators of Human Papillomavirus Vaccination Among Adolescents in Montana. Public Health Rep. 2020 Nov/Dec; 135(6):842-850.
    View in: PubMed
    Score: 0.098
  4. White Paper on studying the safety of the childhood immunization schedule in the Vaccine Safety Datalink. Vaccine. 2016 Feb 15; 34 Suppl 1:A1-A29.
    View in: PubMed
    Score: 0.071
  5. Addressing Parental Vaccine Concerns: Engagement, Balance, and Timing. PLoS Biol. 2015 Aug; 13(8):e1002227.
    View in: PubMed
    Score: 0.069
  6. Pharmacotherapy for incident attention-deficit/hyperactivity disorder: practice patterns and quality metrics. Curr Med Res Opin. 2014 Aug; 30(8):1687-99.
    View in: PubMed
    Score: 0.062
  7. Safety of diphtheria, tetanus, acellular pertussis and inactivated poliovirus (DTaP-IPV) vaccine. Vaccine. 2014 May 23; 32(25):3019-24.
    View in: PubMed
    Score: 0.062
  8. Patterns of care and persistence after incident elevated blood pressure. Pediatrics. 2013 Aug; 132(2):e349-55.
    View in: PubMed
    Score: 0.059
  9. Human papillomavirus vaccination practices: a survey of US physicians 18 months after licensure. Pediatrics. 2010 Sep; 126(3):425-33.
    View in: PubMed
    Score: 0.048
  10. Adolescent immunization delivery in school-based health centers: a national survey. J Adolesc Health. 2009 Nov; 45(5):445-52.
    View in: PubMed
    Score: 0.045
  11. Use of COVID-19 Vaccines for Persons Aged =6 Months: Recommendations of the Advisory Committee on Immunization Practices - United States, 2024-2025. MMWR Morb Mortal Wkly Rep. 2024 Sep 19; 73(37):819-824.
    View in: PubMed
    Score: 0.032
  12. COVID-19 Vaccination in the First Trimester and Major Structural Birth Defects Among Live Births. JAMA Pediatr. 2024 Aug 01; 178(8):823-829.
    View in: PubMed
    Score: 0.032
  13. Lack of Evidence for Vaccine-Associated Enhanced Disease From COVID-19 Vaccines Among Adults in the Vaccine Safety Datalink. Pharmacoepidemiol Drug Saf. 2024 08; 33(8):e5863.
    View in: PubMed
    Score: 0.032
  14. Coronavirus Disease 2019 (COVID-19) Vaccination and Stillbirth in the Vaccine Safety Datalink. Obstet Gynecol. 2024 Aug 01; 144(2):215-222.
    View in: PubMed
    Score: 0.032
  15. Post-COVID conditions following COVID-19 vaccination: a retrospective matched cohort study of patients with SARS-CoV-2 infection. Nat Commun. 2024 May 22; 15(1):4101.
    View in: PubMed
    Score: 0.032
  16. Use of an Additional Updated 2023-2024 COVID-19 Vaccine Dose for Adults Aged =65 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, 2024. MMWR Morb Mortal Wkly Rep. 2024 Apr 25; 73(16):377-381.
    View in: PubMed
    Score: 0.031
  17. Trends of Antihypertensive Prescription Among US Adults From 2010 to 2019 and Changes Following Treatment Guidelines: Analysis of Multicenter Electronic Health Records. J Am Heart Assoc. 2024 May 07; 13(9):e032197.
    View in: PubMed
    Score: 0.031
  18. Attitudes Toward COVID-19 Vaccines Among Pregnant and Recently Pregnant Individuals. JAMA Netw Open. 2024 Apr 01; 7(4):e245479.
    View in: PubMed
    Score: 0.031
  19. Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger - United States, 2024. MMWR Morb Mortal Wkly Rep. 2024 Jan 11; 73(1):6-10.
    View in: PubMed
    Score: 0.031
  20. Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older - United States, 2024. MMWR Morb Mortal Wkly Rep. 2024 Jan 11; 73(1):11-15.
    View in: PubMed
    Score: 0.031
  21. Use of Updated COVID-19 Vaccines 2023-2024 Formula for Persons Aged =6 Months: Recommendations of the Advisory Committee on Immunization Practices - United States, September 2023. MMWR Morb Mortal Wkly Rep. 2023 Oct 20; 72(42):1140-1146.
    View in: PubMed
    Score: 0.030
  22. Simultaneous administration of mRNA COVID-19 bivalent booster and influenza vaccines. Vaccine. 2023 09 07; 41(39):5678-5682.
    View in: PubMed
    Score: 0.030
  23. Interim Recommendations for Use of Bivalent mRNA COVID-19 Vaccines for Persons Aged =6 Months - United States, April 2023. MMWR Morb Mortal Wkly Rep. 2023 Jun 16; 72(24):657-662.
    View in: PubMed
    Score: 0.030
  24. Interim Recommendations from the Advisory Committee on Immunization Practices for the Use of Bivalent Booster Doses of COVID-19 Vaccines - United States, October 2022. MMWR Morb Mortal Wkly Rep. 2022 Nov 11; 71(45):1436-1441.
    View in: PubMed
    Score: 0.028
  25. Cholera Vaccine: Recommendations of the Advisory Committee on Immunization Practices, 2022. MMWR Recomm Rep. 2022 09 30; 71(2):1-8.
    View in: PubMed
    Score: 0.028
  26. Travelers and travel vaccines at six health care systems in the Vaccine Safety Datalink. Vaccine. 2022 09 29; 40(41):5904-5911.
    View in: PubMed
    Score: 0.028
  27. Interim Recommendation of the Advisory Committee on Immunization Practices for Use of the Novavax COVID-19 Vaccine in Persons Aged =18 years - United States, July 2022. MMWR Morb Mortal Wkly Rep. 2022 Aug 05; 71(31):988-992.
    View in: PubMed
    Score: 0.028
  28. Health Care Utilization in the 6 Months Following SARS-CoV-2 Infection. JAMA Netw Open. 2022 08 01; 5(8):e2225657.
    View in: PubMed
    Score: 0.028
  29. Interim Recommendations of the Advisory Committee on Immunization Practices for Use of Moderna and Pfizer-BioNTech COVID-19 Vaccines in Children Aged 6 Months-5 Years - United States, June 2022. MMWR Morb Mortal Wkly Rep. 2022 Jul 01; 71(26):859-868.
    View in: PubMed
    Score: 0.028
  30. The Advisory Committee on Immunization Practices' Recommendation for Use of Moderna COVID-19 Vaccine in Adults Aged =18 Years and Considerations for Extended Intervals for Administration of Primary Series Doses of mRNA COVID-19 Vaccines - United States, February 2022. MMWR Morb Mortal Wkly Rep. 2022 Mar 18; 71(11):416-421.
    View in: PubMed
    Score: 0.027
  31. A decade of data: Adolescent vaccination in the vaccine safety datalink, 2007 through 2016. Vaccine. 2022 02 23; 40(9):1246-1252.
    View in: PubMed
    Score: 0.027
  32. Receipt of COVID-19 Vaccine During Pregnancy and Preterm or Small-for-Gestational-Age at Birth - Eight Integrated Health Care Organizations, United States, December 15, 2020-July 22, 2021. MMWR Morb Mortal Wkly Rep. 2022 Jan 07; 71(1):26-30.
    View in: PubMed
    Score: 0.027
  33. Monitoring vaccine safety using the vaccine safety Datalink: Assessing capacity to integrate data from Immunization Information systems. Vaccine. 2022 01 31; 40(5):752-756.
    View in: PubMed
    Score: 0.027
  34. The Childhood Vaccination Schedule and the Lack of Association With Type 1 Diabetes. Pediatrics. 2021 12 01; 148(6).
    View in: PubMed
    Score: 0.027
  35. The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Children Aged 5-11 Years - United States, November 2021. MMWR Morb Mortal Wkly Rep. 2021 Nov 12; 70(45):1579-1583.
    View in: PubMed
    Score: 0.026
  36. The Advisory Committee on Immunization Practices' Interim Recommendations for Additional Primary and Booster Doses of COVID-19 Vaccines - United States, 2021. MMWR Morb Mortal Wkly Rep. 2021 Nov 05; 70(44):1545-1552.
    View in: PubMed
    Score: 0.026
  37. Use of Pfizer-BioNTech COVID-19 Vaccine in Persons Aged =16 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, September 2021. MMWR Morb Mortal Wkly Rep. 2021 Sep 24; 70(38):1344-1348.
    View in: PubMed
    Score: 0.026
  38. Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices - United States, July 2021. MMWR Morb Mortal Wkly Rep. 2021 Aug 13; 70(32):1094-1099.
    View in: PubMed
    Score: 0.026
  39. Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices - United States, June 2021. MMWR Morb Mortal Wkly Rep. 2021 Jul 09; 70(27):977-982.
    View in: PubMed
    Score: 0.026
  40. COVID-19 Vaccination Coverage Among Pregnant Women During Pregnancy - Eight Integrated Health Care Organizations, United States, December 14, 2020-May 8, 2021. MMWR Morb Mortal Wkly Rep. 2021 Jun 18; 70(24):895-899.
    View in: PubMed
    Score: 0.026
  41. The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Adolescents Aged 12-15 Years - United States, May 2021. MMWR Morb Mortal Wkly Rep. 2021 May 21; 70(20):749-752.
    View in: PubMed
    Score: 0.026
  42. Updated Recommendations from the Advisory Committee on Immunization Practices for Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients - United States, April 2021. MMWR Morb Mortal Wkly Rep. 2021 Apr 30; 70(17):651-656.
    View in: PubMed
    Score: 0.025
  43. Associations Between Socioeconomic Context and Congenital Heart Disease Related Outcomes in Adolescents and Adults. Am J Cardiol. 2021 01 15; 139:105-115.
    View in: PubMed
    Score: 0.025
  44. Effects of the COVID-19 Pandemic on Routine Pediatric Vaccine Ordering and Administration - United States, 2020. MMWR Morb Mortal Wkly Rep. 2020 May 15; 69(19):591-593.
    View in: PubMed
    Score: 0.024
  45. Association Between Rotavirus Vaccination and Type 1 Diabetes in Children. JAMA Pediatr. 2020 05 01; 174(5):455-462.
    View in: PubMed
    Score: 0.024
  46. Order of Live and Inactivated Vaccines and Risk of Non-vaccine-targeted Infections in US Children 11-23 Months of Age. Pediatr Infect Dis J. 2020 03; 39(3):247-253.
    View in: PubMed
    Score: 0.024
  47. Near Real-Time Surveillance to Assess the Safety of the 9-Valent Human Papillomavirus Vaccine. Pediatrics. 2019 12; 144(6).
    View in: PubMed
    Score: 0.023
  48. Racial/Ethnic Disparities in the Prevalence of Diabetes and Prediabetes by BMI: Patient Outcomes Research To Advance Learning (PORTAL) Multisite Cohort of Adults in the U.S. Diabetes Care. 2019 12; 42(12):2211-2219.
    View in: PubMed
    Score: 0.023
  49. An examination of racial and ethnic differences within a sample of Hispanic, white (non-Hispanic), and African American Medicaid-eligible pregnant substance abusers. The MOTHERS Project. J Subst Abuse Treat. 1997 Sep-Oct; 14(5):489-98.
    View in: PubMed
    Score: 0.020
  50. Cardiometabolic Risk Factors Among 1.3 Million Adults With Overweight or Obesity, but Not Diabetes, in 10 Geographically Diverse Regions of the United States, 2012-2013. Prev Chronic Dis. 2017 03 09; 14:E22.
    View in: PubMed
    Score: 0.019
  51. Characteristics and treatment needs of sexually abused pregnant women in drug rehabilitation. The Massachusetts MOTHERS Project. J Subst Abuse Treat. 1997 Mar-Apr; 14(2):191-6.
    View in: PubMed
    Score: 0.019
  52. Change in Weight Status and Development of Hypertension. Pediatrics. 2016 Mar; 137(3):e20151662.
    View in: PubMed
    Score: 0.018
  53. Vaccination and 30-Day Mortality Risk in Children, Adolescents, and Young Adults. Pediatrics. 2016 Mar; 137(3):e20152970.
    View in: PubMed
    Score: 0.018
  54. Comparing US paediatric and adult weight classification at the transition from late teenage to young adulthood. Pediatr Obes. 2015 Oct; 10(5):371-9.
    View in: PubMed
    Score: 0.016
  55. Lipid screening in children and adolescents in community practice: 2007 to 2010. Circ Cardiovasc Qual Outcomes. 2014 Sep; 7(5):718-26.
    View in: PubMed
    Score: 0.016
  56. Timely versus delayed early childhood vaccination and seizures. Pediatrics. 2014 Jun; 133(6):e1492-9.
    View in: PubMed
    Score: 0.016
  57. Absence of associations between influenza vaccines and increased risks of seizures, Guillain-Barré syndrome, encephalitis, or anaphylaxis in the 2012-2013 season. Pharmacoepidemiol Drug Saf. 2014 May; 23(5):548-53.
    View in: PubMed
    Score: 0.015
  58. Uptake, coverage, and completion of quadrivalent human papillomavirus vaccine in the vaccine safety Datalink, July 2006-June 2011. J Adolesc Health. 2013 Nov; 53(5):637-41.
    View in: PubMed
    Score: 0.015
  59. Prevalence of obesity and extreme obesity in children aged 3-5 years. Pediatr Obes. 2014 Jun; 9(3):167-75.
    View in: PubMed
    Score: 0.015
  60. Things are not as bad as they seem: physicians' ability to predict their clinical practice when a new vaccine becomes available. Healthc Policy. 2013 May; 8(4):71-85.
    View in: PubMed
    Score: 0.015
  61. A population-based cohort study of undervaccination in 8 managed care organizations across the United States. JAMA Pediatr. 2013 Mar 01; 167(3):274-81.
    View in: PubMed
    Score: 0.014
  62. Prehypertension and hypertension in community-based pediatric practice. Pediatrics. 2013 Feb; 131(2):e415-24.
    View in: PubMed
    Score: 0.014
  63. Adapting group sequential methods to observational postlicensure vaccine safety surveillance: results of a pentavalent combination DTaP-IPV-Hib vaccine safety study. Am J Epidemiol. 2013 Jan 15; 177(2):131-41.
    View in: PubMed
    Score: 0.014
  64. Risk of confirmed Guillain-Barre syndrome following receipt of monovalent inactivated influenza A (H1N1) and seasonal influenza vaccines in the Vaccine Safety Datalink Project, 2009-2010. Am J Epidemiol. 2012 Jun 01; 175(11):1100-9.
    View in: PubMed
    Score: 0.014
  65. The risk of immune thrombocytopenic purpura after vaccination in children and adolescents. Pediatrics. 2012 Feb; 129(2):248-55.
    View in: PubMed
    Score: 0.013
  66. Safety of zoster vaccine in adults from a large managed-care cohort: a Vaccine Safety Datalink study. J Intern Med. 2012 May; 271(5):510-20.
    View in: PubMed
    Score: 0.013
  67. Pediatricians' attitudes about collaborations with other community vaccinators in the delivery of seasonal influenza vaccine. Acad Pediatr. 2012 Jan-Feb; 12(1):26-35.
    View in: PubMed
    Score: 0.013
  68. Adherence to the Advisory Committee on Immunization Practices recommendation to prevent injuries from postvaccination syncope: a national physician survey. Am J Prev Med. 2011 Sep; 41(3):317-21.
    View in: PubMed
    Score: 0.013
  69. H1N1 and seasonal influenza vaccine safety in the vaccine safety datalink project. Am J Prev Med. 2011 Aug; 41(2):121-8.
    View in: PubMed
    Score: 0.013
  70. Safety of trivalent inactivated influenza vaccine in children aged 24 to 59 months in the vaccine safety datalink. Arch Pediatr Adolesc Med. 2011 Aug; 165(8):749-55.
    View in: PubMed
    Score: 0.013
  71. Influenza vaccine delivery delays from the perspective of primary care physicians. Am J Prev Med. 2011 Jun; 40(6):620-4.
    View in: PubMed
    Score: 0.013
  72. Late-season influenza vaccination: a national survey of physician practice and barriers. Am J Prev Med. 2010 Jul; 39(1):69-73.
    View in: PubMed
    Score: 0.012
  73. Barriers to the use of herpes zoster vaccine. Ann Intern Med. 2010 May 04; 152(9):555-60.
    View in: PubMed
    Score: 0.012
  74. Knowledge of interim recommendations and use of Hib vaccine during vaccine shortages. Pediatrics. 2010 May; 125(5):914-20.
    View in: PubMed
    Score: 0.012
  75. High influenza vaccination coverage in children with high-risk conditions during a vaccine shortage. Arch Pediatr Adolesc Med. 2009 May; 163(5):426-31.
    View in: PubMed
    Score: 0.011
  76. Impact of the 2004-2005 influenza vaccine shortage on pediatric practice: a national survey. Pediatrics. 2009 Feb; 123(2):e186-92.
    View in: PubMed
    Score: 0.011
  77. Impact of a severe influenza vaccine shortage on primary care practice. Am J Prev Med. 2007 Dec; 33(6):486-91.
    View in: PubMed
    Score: 0.010
  78. Will pediatricians adopt the new rotavirus vaccine? Pediatrics. 2007 Jan; 119(1):1-10.
    View in: PubMed
    Score: 0.009
  79. Effects of a statewide carve out on spending and access to substance abuse treatment in Massachusetts, 1992 to 1996. Health Serv Res. 2001 Dec; 36(6 Pt 2):32-44.
    View in: PubMed
    Score: 0.007

© 2024 Kaiser Permanente